Deyin Guo

4PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursReaction engineering (excl. nuclear reactions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 25, 2019
Correction to: CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4+ T cells and hematopoietic stem/progenitor cells promotes HIV-1 resistance and CD4+ T cell enrichment in humanized mice.

Qiaoqiao Xiao, Shuliang Chen, Qiankun Wang

|Jun 13, 2019
CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4+ T cells and hematopoietic stem/progenitor cells promotes HIV-1 resistance and CD4+ T cell enrichment in humanized mice.

Qiaoqiao Xiao, Shuliang Chen, Qiankun Wang

|Nov 17, 2017
Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.

Qiankun Wang, Shuliang Chen, Qiaoqiao Xiao

|Sep 15, 2017
Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4+ T cells from HIV-1 infection.

Zhepeng Liu, Shuliang Chen, Xu Jin

Pageof 1

Frequent Collaborators